Rakuten Medical, Inc., a global biotechnology company developing and commercializing Alluminox™ platform-based photoimmunotherapy, today announced that its third drug candidate, RM-0256, has been ...

Purple Biotech Ltd. ("Purple Biotech" or "the Company") (NASDAQ/TASE: PPBT), a clinical-stage company developing ...

Researchers at the Ragon Institute have made a significant discovery about how antibodies can directly enhance the body's ...

DelveInsight's Chronic Kidney Disease pipeline report depicts a robust space with 75+ active players working to develop 80+ ...

If your dog is suffering from allergies, you’re likely trying to decide between Cytopoint vs Apoquel, the two most commonly prescribed allergy medications for dogs. In this comparison guide, we’ll ...

The injectable drug delivery market is a critical segment within the pharmaceutical and healthcare industries, primarily focusing on the administration of medications through injections. This method ...

There have been important recent advances in the management of Crohn's disease, including new classes of biological or small molecule therapies, an appreciation that endoscopic mucosal healing results ...

DelveInsight's,“ Advanced Melanoma Pipeline Insight 2025 ” report provides comprehensive insights about 55+ companies and 60+ pipel ...

Malappuram: Health Minister Veena George on Friday announced that the Nipah-infected patient from Valanchery has tested ...

The Rare Inflammatory Disease Treatment Market has garnered a market value of USD 12,664 Million in 2021, anticipated to register a positive CAGR of 4.6% in the forecast period 2022 to 2028 and reach ...

601A is a recombinant humanized anti-VEGF monoclonal antibody for injection. The proposed main indications are age-related ...